Zynerba Pharmaceuticals (ZYNE): ZYNE upgraded to $17.00. Look for more o...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3819
Posts	239216
Boards Moderated	0
Alias Born	07/30/2007

cjstocksup

Re: LittleBird post# 887

Monday, 10/02/2017 11:33:43 AM

Monday, October 02, 2017 11:33:43 AM

ZYNE upgraded to $17.00. Look for more of these.
UPDATE: Cantor Fitzgerald Upgrades Zynerba Pharmaceuticals (ZYNE) to Overweight
October 2, 2017 5:55 AM

(Updated - October 2, 2017 6:54 AM EDT)

(updated to add analyst comment)

Cantor Fitzgerald upgraded Zynerba Pharmaceuticals (NASDAQ: ZYNE) from Neutral to Overweight with a price target of $17.00 (from $4.00).

Analyst Elemer Piros cites the phase 2a data in Fragile X syndrome noting encouragement from the potential for ZYN002 in treating the disease. The analyst sees upside catalysts from additional regulatory clarity on late-stage development which is slated for 2018.

For an analyst ratings summary and ratings history on Zynerba Pharmaceuticals click here. For more ratings news on Zynerba Pharmaceuticals click here.

Shares of Zynerba Pharmaceuticals closed at $8.36 Friday.
https://www.streetinsider.com/dr/news.php?id=13346899&gfv=1